Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It only takes 1.
My take is that there are 7.3 Billion people that are potential customers for SRNE’s products. The first FDA approval for the myriad of COVID products under development should allay all concerns.
And COVID-19 has been in existence for how long? You can’t rush science. Time will tell if SRNE has the goods.
Rome wasn’t built in a day.
Favorable TLD causes FPRX to soar. Next up NWBO!!
Thanks for the clarification!
You are right. Unfortunately access to it is now locked. But when it was up for viewing there was a very detailed and well written description of the product. I am hopeful that EUA will be shortly granted.
This just made my day!! COVI-TRACK looks locked and loaded for upcoming distribution. After loading this URL tap on COVI-TRACK and type in Leslie as the password:
https://leslieroolvinkrocks.com/
SRNE has a broad array of products with home run potential. I am buying on any weakness.
IMO the Big Boys like $REGN, $GILD, $PFE, $AMGN, $LLY, etc. could be looking at $SRNE as a potential acquisition target with its vast product pipeline and modest market cap.
Sorrento mentioned in Forbes article with Regeneron, Eli Lilly and Astra Zeneca as having rival COVID-19 antibody drugs being tested.
https://www.forbes.com/sites/leahrosenbaum/2020/10/02/what-you-need-to-know-about-trumps-experimental-coronavirus-antibody-treatment/
Congratulations to Dr. Ji and SRNE stockholders!! This is the start of a string of very favorable news with SRNE soon becoming a household name IMO!!!
Where is the link for the Queensland news?
Home rapid COVID saliva test is the key to opening up the economy. SRNE/Columbia are in the driver’s seat. Yale’s COVID saliva test is not a realistic approach.
The IED's used in last night's attack in Manhattan, while not being called an act of terrorism by NYC officials, is very similar to the terrorist bombs used in the 2013 Boston Marathon.
NBC News: Bomb Dogs Failed Dozens of Tests at 10 Large U.S. Airports
http://www.nbcnews.com/news/us-news/bomb-dogs-failed-dozens-tests-10-large-u-s-airports-n648466
TSA Awards Implant Sciences Potential $71 Million In Orders For Trace Detectors
DefenseDaily.com | 09/15/2016 | Calvin Biesecker
Platinum's NAVB was up another 30%+ today to $1.10.
Platinum Partners' NAVB +136% today on the sale of its flagship Lymphoseek product to Cardinal Health.
IMSC +6.2% crosses above 60 day MA $0.5461. Last $0.547 10:13AM EDT 08/04/2016. Conference call at 16:15 today regarding potential acquisition of hover board technology for defense and security applications.
$IMSC +6.2% crosses above 60 day MA $0.5461. Last $0.547 10:13AM EDT 08/04/2016. Conference call at 16:15 today regarding potential acquisition of hover board technology for defense and security applications.
IMSC 0.48 - Implant Sciences +20%. Pending acquisition will bring defense & security applications for flying hover boards technology. #TSA
$IMSC 0.48 - Implant Sciences +20%. Pending acquisition will bring defense & security applications for flying hover boards technology. #TSA
Another article from Popular Science:
http://www.popsci.com/homeland-security-company-wants-to-sell-hoverboards-to-military
$IMSC - Implant Sciences Announces Letter of Intent to Acquire Zapata Industries, Plan to Extinguish Debt and Uplist to NASDAQ8:15 AM ET, 07/21/2016 - PR Newswire
WILMINGTON, Mass., July 21, 2016 /PRNewswire/ -- <WSODTagging BridgeSymbol="US;IMSC" WSODIssue="166290">Implant Sciences Corporation</WSODTagging> (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, is pleased to announce the signing of a letter of intent to acquire Zapata Industries SAS of Marseilles, France. Zapata is a profitable and debt-free company with commercial, defense, and homeland security technology applications.
Zapata Industries (www.zapata-industries.com) is the undisputed leader in developing and manufacturing single user hydro-and jet-powered technologies and products. Zapata's proprietary methodology, algorithms, and patented designs are currently commercialized and in development within recreation, entertainment, military, medical, and industrial sectors.
In 2016 Zapata achieved its proof of concept milestone by producing the safest, most reliable, lightest, fastest, and least expensive personal flight system ever created with the unveiling of the Flyboard Air®. The Flyboard Air® utilizes Zapata Industries' proprietary algorithms and balance methodology to direct jet engines to act both independently and harmoniously. This unique technology not only provides unparalleled maneuverability speed and ease of use but it also provides full flight redundancy, making the platform as safe as any airplane with as little as 20 hours of training. Zapata Industries can commercialize its breakthrough technology with products ranging from flying medical stretchers and Jetbikes to floating rescue stations, scaffoldings and unmanned heavy payload delivery drones. The performance parameters of the Flyboard Air® provide undisputed proof that Zapata technology is commercially viable for advanced applications within the military, industrial, and medical fields. Aviation Experts see this revolutionary transportation platform as meaningfully disruptive to the air transportation industry. Early industry reaction to the Flyboard Air®, has been overwhelming and the Flyboard Air® has become an internet sensation. Digital Trends, April 14, 2016, calls it "awesome beyond words … we see no limit to the future of a device like the Flyboard Air, including search and rescue, military applications and of course, the best way to get to just about anywhere." (http://www.digitaltrends.com/dt-daily/hoax-or-breakthrough-flyboard-air-videos-stun-the-internet/)
See the following video, Zapata Industries — The Leader in Personal Flight & Aviation: https://youtu.be/_A0sdkZ4Vlk
Implant Sciences continues to evolve and innovate to provide leading edge Homeland and Defense Security Solutions and has emerged as the market leader in Explosive Trace Detection (ETD) technologies. Late last year, the company announced that it had begun a process to evaluate strategic opportunities in response to its rapid growth (400% in 2016) and changing market conditions. While the Board continues to evaluate a number of offers it has received to sell the ETD business, the company believes that the opportunity afforded by the acquisition of Zapata Industries, with its revolutionary technology and robust growth, will build on the success achieved with the ETD business and add significant shareholder value to allow the company to remain a leading innovator for Homeland Security and Defense technologies.
The company's agreement with Zapata, subject to shareholder approval, positions the company to emerge debt-free (pending the restructuring which could include a sale of the ETD business or a capital raise) with at least $20 million in cash for working capital on the balance sheet in exchange for $15 million, 60% equity and 50 million warrants exercisable at $1.50 per share. Upon conclusion of the restructuring and meeting NASDAQ listing requirements, the company will pursue an uplisting to the NASDAQ Marketplace.
Robert Liscouski, President and Board Member of Implant Sciences, commented, "The potential acquisition of Zapata brings Implant Sciences a best-in-class personal balance and flight technology that has far reaching military and consumer applications. We are beyond excited to have visionaries like Franky Zapata and his team on board and we are thrilled to allow for shareholders to benefit from the many breakthrough products he has already invented and the new innovations he will be unveiling in coming months and years."
Coinciding with this press release, the company is filing a detailed 8-K in accordance with SEC guidelines.
About Zapata Industries
Zapata Industries is the undisputed leader in developing and manufacturing hydro- and jet-powered technologies and products. Zapata's proprietary methodology, algorithms, and patented designs are currently commercialized and in development within the recreation, entertainment, military, medical, and industrial sectors.
Zapata Industries' founder, world champion jetski racer Franky Zapata, launched Zapata Racing to satisfy his passion to invent aftermarket products to make the world's fastest personal water craft. With unparalleled performance, Zapata products quickly became a racing requirement to achieve the competitive edge necessary to win. With the desire to go even faster, Zapata shifted focus, and began manufacturing the fastest sit down and stand up jetskis in the racing world.
In 2012 Zapata launched the revolutionary Flyboard®, kickstarting a niche $200 million Hydroflight Sports and Recreation industry. Hydroflight is still in its earliest stages of growth and development, and the unwaning market demand provides a view for Zapata's opportunity to further commercialize the industry in the coming years.
In 2016 Zapata achieved it's proof of concept goal producing the safest, most reliable, lightest, fastest, and least expensive personal flight system ever created with the unveiling of the Flyboard Air®. The Flyboard Air® utilizes Zapata Industries' proprietary algorithms and balance methodology to direct jet engines to act both independently and harmoniously. The performance parameters of the Flyboard Air® provide undisputed proof that Zapata technology is commercially viable for advanced applications within the military, industrial, and medical fields.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The company's team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 70 countries worldwide. The company's explosive trace detection products have received approvals and certifications from several international regulatory agencies, including the TSA in the U.S., STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China. It also received a GSN 2013 Homeland Security Award for "Best Explosives Detection Solution". All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on Implant Sciences and its products, please visit the Company's website at www.implantsciences.com.
Cautionary Note Regarding Forward-Looking Statements
This press release and any related statements of management and representatives of Implant Sciences Corporation (the "Company") contain "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to significant risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that the Company will be required to repay all of its indebtedness to secured lenders by the due dates; the risk that if the Company is unable to satisfy its obligations to its secured lenders and to raise additional capital to fund operations, lenders may seize the Company's assets and its business may fail; the Company continues to incur substantial operating losses and may never generate recurring revenue or profitability; the Company's independent registered public accounting firm has expressed substantial doubt as to the Company's ability to continue as a going concern; there is no guarantee that the Transportation Security Administration (TSA) or any other U.S. or foreign government and law enforcement agencies or commercial consumers will purchase any of the Company's explosives detection products or that any new products which the Company may develop will be accepted by the TSA or by such other governments, agencies or consumers; economic, political and other risks associated with international sales and operations could adversely affect the Company's sales; liability claims related to the Company's products or the Company's handling of hazardous materials could damage the Company's reputation and have a material adverse effect on the Company's financial results; the Company's business is subject to intense competition; the Company's markets are subject to rapid technology change and the Company's viability will depend on its ability to develop and introduce new products; the Company may not be able to retain its management and key employees or identify, hire and retain additional personnel as needed; the Company may not be able to enforce its patent and other intellectual property rights or operate without infringing on the proprietary rights of others; and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could cause the actual results to differ materially from those anticipated in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Contact:
Implant Sciences CorporationCompany Contact 978-752-1700 x116
Investor Contact Glenn King732-747-0702
Video - https://www.youtube.com/watch?v=_A0sdkZ4Vlk
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/implant-sciences-announces-letter-of-intent-to-acquire-zapata-industries-plan-to-extinguish-debt-and-uplist-to-nasdaq-300301936.html
SOURCE Implant Sciences Corporation
LLL 52 week high $150.89
Last $151.19 10:15AM EDT 07/19/2016
LLL 52 week high $150.77
Last $150.80 11:18AM EDT 07/11/2016
$LLLI 0.031 +68.5% following last night's outrageous violence in #Dallas. See also $TASR, $SWHC, $RGR and $DGLY.
LLL 52 week high $148.01
Last $148.12 10:59AM EDT 07/06/2016
$IMSC $0.615 in Briefing.com:
Implant Sciences awarded Standing Offer from Canadian Air Transport Security Authority for up to 340 of QS-B220 desktop explosives trace detectors
10:23 AM ET, 06/28/2016 - Briefing.com
These systems are to be deployed over the course of approximately the next two years to Canadian airports for passenger and baggage screening. Implant Sciences' ETDs have been deployed to more than 160 airports over the last year. This order is in addition to the QS-B220 win last year of CATSA's competitive bid for 112 ETDs.
$IMSC in Briefing.com:
Implant Sciences awarded Standing Offer from Canadian Air Transport Security Authority for up to 340 of QS-B220 desktop explosives trace detectors
10:23 AM ET, 06/28/2016 - Briefing.com
These systems are to be deployed over the course of approximately the next two years to Canadian airports for passenger and baggage screening. Implant Sciences' ETDs have been deployed to more than 160 airports over the last year. This order is in addition to the QS-B220 win last year of CATSA's competitive bid for 112 ETDs.
Fox News Alert: ISIS calls for new attacks after Brexit.
Any thoughts on why IMSC is one of a handful of stocks that is green today when the markets are taking a bloodbath?
Very true. UK isolationism will translate into stronger demand for security products and services.
A clarifying statement by IMSC management is needed here to sort out what is going on with the share price.
Implant Sciences is simply the best.
US Airport security in the news again. Fox News reporting that shots have been fired at Dallas Love Field Airport.